$QTI
QT IMAGING HOLDINGS, INC. Stock $qti

$qti Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000119312524075608 Filed on March 25, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$1.362M	$0.00	$0.00
YoY Change
Cost Of Revenue	$602.1K
YoY Change	1192.66%
Gross Profit	$760.1K
YoY Change	-2048.27%
Gross Profit Margin	55.8%
Selling, General & Admin	$5.696M	$743.9K	$4.928M
YoY Change	222.3%	-53.24%	15.16%
% of Gross Profit	749.42%
Research & Development	$642.5K
YoY Change	52.3%
% of Gross Profit	84.54%
Depreciation & Amortization	$98.87K
YoY Change	-15.37%
% of Gross Profit	13.01%
Operating Expenses	$6.339M	$743.9K	$4.928M
YoY Change	258.66%	-53.24%	15.16%
Operating Profit	-$5.579M		-$4.928M
YoY Change	215.65%		15.16%
Interest Expense	-$599.0K	$233.4K	$219.7K
YoY Change	-1495.75%	-28.55%	851.1%
% of Operating Profit
Other Income/Expense, Net	-$1.104M	$23.50K	$14.95K
YoY Change	110305.0%	-531.99%	-96.11%
Pretax Income	-$4.299M	-$487.0K	-$3.605M
YoY Change	214.23%	-61.64%	57.6%
Income Tax		$84.80K	$419.1K
% Of Pretax Income
Net Earnings	-$4.299M	-$571.8K	-$4.025M
YoY Change	191.85%	-58.34%	45.07%
Net Earnings / Revenue	-315.57%
Basic Earnings Per Share	-$0.33		-$0.78
Diluted Earnings Per Share	-$0.33	-$0.05	-$0.78
COMMON SHARES
Basic Shares Outstanding	21.44M	8.660M	6.540M
Diluted Shares Outstanding	13.23M shares		6.540M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.620M	$2.000K	$2.000K
YoY Change	1478.1%	-97.44%	-97.44%
Cash & Equivalents	$5.640M	$2.438K
Short-Term Investments
Other Short-Term Assets	$1.215M	$94.00K	$94.00K
YoY Change	989.85%	-45.51%	-45.51%
Inventory	$4.116M	$4.418M
Prepaid Expenses
Receivables	$482.4K	$1.290K
Other Receivables	$0.00
Total Short-Term Assets	$11.43M	$96.45K	$96.00K
YoY Change	2344.99%	-61.53%	-61.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$154.1K	$490.9K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$23.30M	$23.30M
YoY Change		-44.11%	-44.11%
Other Assets	$39.15K	$39.15K
YoY Change
Total Long-Term Assets	$1.424M	$23.30M	$23.30M
YoY Change	-95.53%	-44.11%	-44.11%
TOTAL ASSETS
Total Short-Term Assets	$11.43M	$96.45K	$96.00K
Total Long-Term Assets	$1.424M	$23.30M	$23.30M
Total Assets	$12.86M	$23.40M	$23.40M
YoY Change	-60.19%	-44.22%	-44.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$711.8K	$767.6K	$768.0K
YoY Change	98.98%	293.52%	293.73%
Accrued Expenses	$2.813M	$893.8K	$4.394M
YoY Change	1610.56%	764.91%	94.39%
Deferred Revenue	$343.7K	$347.6K
YoY Change
Short-Term Debt	$0.00	$4.682M	$4.682M
YoY Change	-100.0%	184.98%	184.98%
Long-Term Debt Due	$130.7K
YoY Change
Total Short-Term Liabilities	$4.371M	$12.68M	$12.68M
YoY Change	-31.75%	202.95%	202.96%
LONG-TERM LIABILITIES
Long-Term Debt	$8.739M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$465.1K	$377.8K	$8.000K
YoY Change	-83.29%	-95.91%	-99.91%
Total Long-Term Liabilities	$465.1K	$377.8K	$8.000K
YoY Change	-83.29%	-95.91%	-99.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.371M	$12.68M	$12.68M
Total Long-Term Liabilities	$465.1K	$377.8K	$8.000K
Total Liabilities	$17.77M	$12.69M	$12.69M
YoY Change	93.41%	-5.42%	-5.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.07M	-$17.10M
YoY Change	51.64%	30.77%
Common Stock	$2.144K	$4.590M
YoY Change	-99.96%	700638.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.914M	-$12.51M	$10.71M
YoY Change
Total Liabilities & Shareholders Equity	$12.86M	$23.40M	$23.40M
YoY Change	-60.19%	-44.22%	-44.22%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$4.299M	-$571.8K	-$4.025M
YoY Change	191.85%	-58.34%	45.07%
Depreciation, Depletion And Amortization	$98.87K
YoY Change	-15.37%
Cash From Operating Activities	-$5.976M	-$620.8K	-$1.944M
YoY Change	992.66%	3.04%	54.1%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$19.92M
YoY Change		-100.0%	-89.64%
Cash From Investing Activities		$0.00	$19.92M
YoY Change		-100.0%	-89.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$32.47K
YoY Change	0.99%
Cash From Financing Activities	$11.43M	501.3K	-18.05M
YoY Change	-220.52%	-25.73%	-90.57%
NET CHANGE
Cash From Operating Activities	-$5.976M	-620.8K	-1.944M
Cash From Investing Activities		0.000	19.92M
Cash From Financing Activities	$11.43M	501.3K	-18.05M
Net Change In Cash	$5.456M	-119.5K	-75.76K
YoY Change	1862.81%	-70.67%	-77.94%
FREE CASH FLOW
Cash From Operating Activities	-$5.976M	-$620.8K	-$1.944M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001844505
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40839
CY2023	dei	Entity Registrant Name EntityRegistrantName	QT Imaging Holdings, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-1728920
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3 Hamilton Landing
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 160
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Novato
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94949
CY2023	dei	City Area Code CityAreaCode	650
CY2023	dei	Local Phone Number LocalPhoneNumber	276-7040
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	QTI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	101856611
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13080129
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13079474
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23398562
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4927599
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4279100
CY2023	us-gaap	Interest Expense InterestExpense	219686
CY2022	us-gaap	Interest Expense InterestExpense	23098
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1526860
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1630398
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3605472
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2287692
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2774307
CY2023	gia	Net Income Loss Attributable To Common Stock Subject To Redemption NetIncomeLossAttributableToCommonStockSubjectToRedemption	1107741
CY2022	gia	Net Income Loss Attributable To Common Stock Subject To Redemption NetIncomeLossAttributableToCommonStockSubjectToRedemption	1143783
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5132332
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6540000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8918238
CY2022	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	54034
CY2022	gia	Temporary Equity Shares Subject To Redemption Value TemporaryEquitySharesSubjectToRedemptionValue	1440963
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2774307
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13079474
CY2023	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	245253
CY2022	gia	Excise Tax Liability Accrued For Common Stock Redemptions ExciseTaxLiabilityAccruedForCommonStockRedemptions	-202341
CY2023	gia	Temporary Equity Shares Subject To Redemption Value TemporaryEquitySharesSubjectToRedemptionValue	1893733
CY2023	gia	Adjustments To Additional Paid In Capital Deferred Underwriting Fees AdjustmentsToAdditionalPaidInCapitalDeferredUnderwritingFees	6440000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4024591
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12514886
CY2023	us-gaap	Profit Loss ProfitLoss	-4024591
CY2022	us-gaap	Profit Loss ProfitLoss	-2774307
CY2023	gia	Change In Fair Value Of Warrant Liability And Related Party Note ChangeInFairValueOfWarrantLiabilityAndRelatedPartyNote	-14953
CY2022	gia	Change In Fair Value Of Warrant Liability And Related Party Note ChangeInFairValueOfWarrantLiabilityAndRelatedPartyNote	-384108
CY2022	gia	Interest Earned On Cash And Marketable Securities Held In Trust Account InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount	1630398
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-78500
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-567733
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-165230
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	829314
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	708704
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	572551
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	166964
CY2023	gia	Increase Decrease In Accrued Legal Fees IncreaseDecreaseInAccruedLegalFees	1342963
CY2022	gia	Increase Decrease In Accrued Legal Fees IncreaseDecreaseInAccruedLegalFees	1931891
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	588145
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-117411
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21437216
CY2023	dei	Auditor Firm AuditorFirmId	207
CY2023	dei	Auditor Name AuditorName	BPM LLP
CY2023	dei	Auditor Location AuditorLocation	San Jose, California
CY2023Q4	us-gaap	Cash Cash	2438
CY2022Q4	us-gaap	Cash Cash	78196
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	94008
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172508
CY2023Q4	us-gaap	Assets Current AssetsCurrent	96446
CY2022Q4	us-gaap	Assets Current AssetsCurrent	250704
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	23302116
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	41561656
CY2023Q4	gia	Interest Receivable On Cash And Marketable Securities Held In Trust Account InterestReceivableOnCashAndMarketableSecuritiesHeldInTrustAccount	0
CY2022Q4	gia	Interest Receivable On Cash And Marketable Securities Held In Trust Account InterestReceivableOnCashAndMarketableSecuritiesHeldInTrustAccount	133211
CY2023Q4	us-gaap	Assets Assets	23398562
CY2022Q4	us-gaap	Assets Assets	41945571
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	767615
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	195064
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3500000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2157037
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893830
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	103344
CY2023Q4	gia	Payable To Related Party Current PayableToRelatedPartyCurrent	1610875
CY2022Q4	gia	Payable To Related Party Current PayableToRelatedPartyCurrent	781561
CY2023Q4	gia	Notes Payable To Related Party Current NotesPayableToRelatedPartyCurrent	1564673
CY2022Q4	gia	Notes Payable To Related Party Current NotesPayableToRelatedPartyCurrent	603880
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1506389
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	257492
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	79162
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	88021
CY2023Q4	gia	Deferred Underwriting Fee Payable Current DeferredUnderwritingFeePayableCurrent	2760000
CY2022Q4	gia	Deferred Underwriting Fee Payable Current DeferredUnderwritingFeePayableCurrent	0
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12682544
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4186399
CY2023Q4	gia	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	7950
CY2022Q4	gia	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	31800
CY2023Q4	gia	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	0
CY2022Q4	gia	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	9200000
CY2023Q4	us-gaap	Liabilities Liabilities	12690494
CY2022Q4	us-gaap	Liabilities Liabilities	13418199
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2114978
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.98
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4014050
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.37
CY2023Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	23222954
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	41606846
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6545000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6545000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6545000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6545000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	655
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	655
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4589179
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17104720
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13080129
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12514886
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13079474
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23398562
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41945571
CY2023	us-gaap	Revenues Revenues	0
CY2022	us-gaap	Revenues Revenues	0
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4927599
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4279100
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4927599
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4279100
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14953
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	384108
CY2023	us-gaap	Interest Expense InterestExpense	219686
CY2022	us-gaap	Interest Expense InterestExpense	23098
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1526860
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1630398
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3605472
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2287692
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	486615
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4024591
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2774307
CY2023	gia	Net Income Loss Attributable To Common Stock Subject To Redemption NetIncomeLossAttributableToCommonStockSubjectToRedemption	1107741
CY2022	gia	Net Income Loss Attributable To Common Stock Subject To Redemption NetIncomeLossAttributableToCommonStockSubjectToRedemption	1143783
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5132332
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3918090
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6540000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6540000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6540000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6540000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.78
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8918238
CY2022	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	54034
CY2022	gia	Temporary Equity Shares Subject To Redemption Value TemporaryEquitySharesSubjectToRedemptionValue	1440963
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2774307
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13079474
CY2022	gia	Excise Tax Liability Accrued For Common Stock Redemptions ExciseTaxLiabilityAccruedForCommonStockRedemptions	-202341
CY2023	gia	Temporary Equity Shares Subject To Redemption Value TemporaryEquitySharesSubjectToRedemptionValue	1893733
CY2023	gia	Adjustments To Additional Paid In Capital Deferred Underwriting Fees AdjustmentsToAdditionalPaidInCapitalDeferredUnderwritingFees	6440000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4024591
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12514886
CY2023	us-gaap	Profit Loss ProfitLoss	-4024591
CY2022	us-gaap	Profit Loss ProfitLoss	-2774307
CY2023	gia	Change In Fair Value Of Warrant Liability And Related Party Note ChangeInFairValueOfWarrantLiabilityAndRelatedPartyNote	-14953
CY2022	gia	Change In Fair Value Of Warrant Liability And Related Party Note ChangeInFairValueOfWarrantLiabilityAndRelatedPartyNote	-384108
CY2023	gia	Interest Earned On Cash And Marketable Securities Held In Trust Account InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount	1526860
CY2022	gia	Interest Earned On Cash And Marketable Securities Held In Trust Account InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount	1630398
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	219686
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	17914
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-78500
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-567733
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-165230
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	829314
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	708704
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	572551
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	166964
CY2023	gia	Increase Decrease In Accrued Legal Fees IncreaseDecreaseInAccruedLegalFees	1342963
CY2022	gia	Increase Decrease In Accrued Legal Fees IncreaseDecreaseInAccruedLegalFees	1931891
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	588145
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-117411
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-8859
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	86238
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1944104
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1261550
CY2023	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	920000
CY2022	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	640000
CY2023	gia	Proceeds From Trust Preferred Investment ProceedsFromTrustPreferredInvestment	20839611
CY2022	gia	Proceeds From Trust Preferred Investment ProceedsFromTrustPreferredInvestment	192881509
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19919611
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	192241509
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	986360
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	640000
CY2023	gia	Proceeds From Related Party Debt Fair Value ProceedsFromRelatedPartyDebtFairValue	1240000
CY2022	gia	Proceeds From Related Party Debt Fair Value ProceedsFromRelatedPartyDebtFairValue	260000
CY2023	gia	Payments For Redemption Of Stock PaymentsForRedemptionOfStock	20277625
CY2022	gia	Payments For Redemption Of Stock PaymentsForRedemptionOfStock	192138312
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	85000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-75758
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-343353
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78196
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	421549
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2438
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78196
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	427977
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	400377
CY2023	gia	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	1893733
CY2022	gia	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	1440963
CY2023	gia	Excise Tax On Stock Redemptions ExciseTaxOnStockRedemptions	202341
CY2022	gia	Excise Tax On Stock Redemptions ExciseTaxOnStockRedemptions	0
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-8859
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	86238
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1944104
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1261550
CY2023	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	920000
CY2022	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	640000
CY2023	gia	Proceeds From Trust Preferred Investment ProceedsFromTrustPreferredInvestment	20839611
CY2022	gia	Proceeds From Trust Preferred Investment ProceedsFromTrustPreferredInvestment	192881509
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19919611
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	192241509
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	986360
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	640000
CY2023	gia	Proceeds From Related Party Debt Fair Value ProceedsFromRelatedPartyDebtFairValue	1240000
CY2022	gia	Proceeds From Related Party Debt Fair Value ProceedsFromRelatedPartyDebtFairValue	260000
CY2023	gia	Payments For Redemption Of Stock PaymentsForRedemptionOfStock	20277625
CY2022	gia	Payments For Redemption Of Stock PaymentsForRedemptionOfStock	192138312
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	85000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18051265
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-191323312
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-75758
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-343353
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78196
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	421549
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2438
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78196
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	427977
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	400377
CY2023	gia	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	1893733
CY2022	gia	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	1440963
CY2023	gia	Excise Tax On Stock Redemptions ExciseTaxOnStockRedemptions	202341
CY2022	gia	Excise Tax On Stock Redemptions ExciseTaxOnStockRedemptions	0
CY2023	gia	Waiver Of Deferred Underwriting Fees WaiverOfDeferredUnderwritingFees	6440000
CY2022	gia	Waiver Of Deferred Underwriting Fees WaiverOfDeferredUnderwritingFees	0
CY2023	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	245253
CY2022	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	54034
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-01-19
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000000
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	gia	Number Of Public Share NumberOfPublicShare	1
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	23000000
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	225400000
CY2021Q3	gia	Payments Of Stock Issuance Costs Net PaymentsOfStockIssuanceCostsNet	13193740
CY2021Q3	gia	Deferred Underwriting Fees DeferredUnderwritingFees	9200000
CY2021Q3	gia	Original Offering Cost OriginalOfferingCost	843740
CY2023	gia	Payments Of Stock Issuance Costs Net PaymentsOfStockIssuanceCostsNet	25000
CY2021Q3	gia	Reimbursement Of Offering Expenses ReimbursementOfOfferingExpenses	1450000
CY2023	gia	Waiver Of Deferred Underwriting Fees WaiverOfDeferredUnderwritingFees	6440000
CY2022	gia	Waiver Of Deferred Underwriting Fees WaiverOfDeferredUnderwritingFees	0
CY2023	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	245253
CY2022	gia	Debt Discount On Note Payable To Related Party DebtDiscountOnNotePayableToRelatedParty	54034
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-01-19
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000000
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	gia	Number Of Public Share NumberOfPublicShare	1
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	23000000
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	225400000
CY2021Q3	gia	Payments Of Stock Issuance Costs Net PaymentsOfStockIssuanceCostsNet	13193740
CY2021Q3	gia	Deferred Underwriting Fees DeferredUnderwritingFees	9200000
CY2021Q3	gia	Original Offering Cost OriginalOfferingCost	843740
CY2023	gia	Payments Of Stock Issuance Costs Net PaymentsOfStockIssuanceCostsNet	25000
CY2021Q3	gia	Reimbursement Of Offering Expenses ReimbursementOfOfferingExpenses	1450000
CY2023	gia	Monthly Extension Of Amendment Description MonthlyExtensionOfAmendmentDescription	The Company’s initial public offering prospectus and Amended and Restated Certificate of Incorporation provided that the Company initially had until September 28, 2022 (the date which was 12 months after the consummation of the Offering) to complete the Business Combination (the “Combination Period”). On September 23, 2022, the Company held a special meeting of its stockholders and the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation that extends the date by which the Company must consummate a Business Combination transaction from September 28, 2022 up to March 28, 2023 in one-month extensions (the “Extension”).
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	960000
CY2023	gia	Proposals Description ProposalsDescription	At the March special meeting, the stockholders approved two proposals: (A) to amend the Company’s Amended and Restated Certificate of Incorporation, giving the Company the right to extend the date by which it has to consummate a Business Combination up to six (6) times for an additional one (1) month each time, from March 28, 2023 to September 28, 2023 provided that the Sponsor (or its designees) must deposit into the Trust Account for each one-month extension funds equal to $100,000 (the “Second Extension”); (B) to amend the Company’s investment management trust agreement, dated as of September 23, 2021, by and between the Company and Continental Stock Transfer & Trust Company, allowing the Company to extend the Combination Period up to six (6) times for an additional one (1) month each time from March 28, 2023 to August 28, 2023 by depositing into the Trust Account for each one-month extension, the sum of $100,000.
CY2023Q4	gia	Number Of Public Shares To Be Redeemed NumberOfPublicSharesToBeRedeemed	995049
CY2023Q4	gia	Percentage Of Shares Sold During Offering PercentageOfSharesSoldDuringOffering	0.043
CY2023	gia	Amount Withdrawn From Trust Account AmountWithdrawnFromTrustAccount	10449625
CY2023Q3	gia	Number Of Public Shares To Be Redeemed NumberOfPublicSharesToBeRedeemed	904023
CY2023Q3	gia	Amount Withdrawn From Trust Account AmountWithdrawnFromTrustAccount	9828000
CY2023	gia	Issued And Outstanding Common Stock Own Percentage IssuedAndOutstandingCommonStockOwnPercentage	0.756
CY2023	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less
CY2023	gia	Public Shares Redemption Percentage PublicSharesRedemptionPercentage	1
CY2023Q1	gia	Monthly Extension Fee Payable MonthlyExtensionFeePayable	160000
CY2023Q3	gia	Monthly Extension Fee Payable MonthlyExtensionFeePayable	100000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17104720
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4024591
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1944104
CY2023	gia	Discription Of Trigger Event Based On Common Stock DiscriptionOfTriggerEventBasedOnCommonStock	when the daily volume-weighted average price is less than $2.00 per share for five consecutive trading days
CY2023Q4	gia	Common Stock Average Par Value Per Share CommonStockAverageParValuePerShare	2
CY2024	gia	Discription Of Having Sufficient Fund DiscriptionOfHavingSufficientFund	P12M
CY2023	gia	Monthly Extension Of Amendment Description MonthlyExtensionOfAmendmentDescription	The Company’s initial public offering prospectus and Amended and Restated Certificate of Incorporation provided that the Company initially had until September 28, 2022 (the date which was 12 months after the consummation of the Offering) to complete the Business Combination (the “Combination Period”). On September 23, 2022, the Company held a special meeting of its stockholders and the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation that extends the date by which the Company must consummate a Business Combination transaction from September 28, 2022 up to March 28, 2023 in one-month extensions (the “Extension”).
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	960000
CY2023	gia	Proposals Description ProposalsDescription	At the March special meeting, the stockholders approved two proposals: (A) to amend the Company’s Amended and Restated Certificate of Incorporation, giving the Company the right to extend the date by which it has to consummate a Business Combination up to six (6) times for an additional one (1) month each time, from March 28, 2023 to September 28, 2023 provided that the Sponsor (or its designees) must deposit into the Trust Account for each one-month extension funds equal to $100,000 (the “Second Extension”); (B) to amend the Company’s investment management trust agreement, dated as of September 23, 2021, by and between the Company and Continental Stock Transfer & Trust Company, allowing the Company to extend the Combination Period up to six (6) times for an additional one (1) month each time from March 28, 2023 to August 28, 2023 by depositing into the Trust Account for each one-month extension, the sum of $100,000.
CY2023Q4	gia	Percentage Of Shares Sold During Offering PercentageOfSharesSoldDuringOffering	0.043
CY2023	gia	Amount Withdrawn From Trust Account AmountWithdrawnFromTrustAccount	10449625
CY2023Q3	gia	Number Of Public Shares To Be Redeemed NumberOfPublicSharesToBeRedeemed	904023
CY2023Q3	gia	Amount Withdrawn From Trust Account AmountWithdrawnFromTrustAccount	9828000
CY2023	gia	Issued And Outstanding Common Stock Own Percentage IssuedAndOutstandingCommonStockOwnPercentage	0.756
CY2023	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less
CY2023	gia	Public Shares Redemption Percentage PublicSharesRedemptionPercentage	1
CY2023Q1	gia	Monthly Extension Fee Payable MonthlyExtensionFeePayable	160000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17104720
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1944104
CY2023	gia	Discription Of Trigger Event Based On Common Stock DiscriptionOfTriggerEventBasedOnCommonStock	when the daily volume-weighted average price is less than $2.00 per share for five consecutive trading days
CY2023Q4	gia	Common Stock Average Par Value Per Share CommonStockAverageParValuePerShare	2
CY2024	gia	Discription Of Having Sufficient Fund DiscriptionOfHavingSufficientFund	P12M
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares	2114978
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares	4014050
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </div>
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	13193740
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares	2114978
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares	4014050
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023	gia	Holding Period Of Shares For Completion Of Initial Business Combination HoldingPeriodOfSharesForCompletionOfInitialBusinessCombination	P6M
CY2023	gia	Period After Completion Of Business Combination To Allow Transfer Of Shares PeriodAfterCompletionOfBusinessCombinationToAllowTransferOfShares	P30D
CY2023	gia	Warrants Transfer Restrictions Period Following Consummation Of Business Combination WarrantsTransferRestrictionsPeriodFollowingConsummationOfBusinessCombination	P1Y
CY2023	gia	Underwriting Discount Per Public Unit Paid In Cash UnderwritingDiscountPerPublicUnitPaidInCash	0.2
CY2023	gia	Deferred Underwriting Commissions Per Public Unit DeferredUnderwritingCommissionsPerPublicUnit	0.4
CY2023Q4	gia	Deferred Underwriting Commissions Payable DeferredUnderwritingCommissionsPayable	9200000
CY2023Q4	gia	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023	gia	Holding Period Of Shares For Completion Of Initial Business Combination HoldingPeriodOfSharesForCompletionOfInitialBusinessCombination	P6M
CY2023	gia	Period After Completion Of Business Combination To Allow Transfer Of Shares PeriodAfterCompletionOfBusinessCombinationToAllowTransferOfShares	P30D
CY2023	gia	Warrants Transfer Restrictions Period Following Consummation Of Business Combination WarrantsTransferRestrictionsPeriodFollowingConsummationOfBusinessCombination	P1Y
CY2023Q4	us-gaap	Fair Value Option Aggregate Differences Long Term Debt Instruments FairValueOptionAggregateDifferencesLongTermDebtInstruments	1560000
CY2023	gia	Underwriting Discount Per Public Unit Paid In Cash UnderwritingDiscountPerPublicUnitPaidInCash	0.2
CY2023	gia	Deferred Underwriting Commissions Per Public Unit DeferredUnderwritingCommissionsPerPublicUnit	0.4
CY2023Q4	gia	Deferred Underwriting Commissions Payable DeferredUnderwritingCommissionsPayable	9200000
CY2023Q4	gia	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	0
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	0
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	133211
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3605472
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2287692
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3605472
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2287692
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3605472
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2287692
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2287692
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	285990
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	342216
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	133129
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	144399
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	486615
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	486615
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	285990
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	342216
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	486615
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	486615
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-757149
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-480415
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-236036
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-184760
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1364927
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1227602
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	486615
CY2023Q4	gia	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	2895226
CY2022Q4	gia	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	1530299
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2895226
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1530299
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2895226
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1530299
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1364927
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1227602
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-757149
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-480415
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-236036
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-184760
CY2023	gia	Income Tax Reconciliation Warrant And Note Payable Revaluation IncomeTaxReconciliationWarrantAndNotePayableRevaluation	47377
CY2022	gia	Income Tax Reconciliation Warrant And Note Payable Revaluation IncomeTaxReconciliationWarrantAndNotePayableRevaluation	-75812
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1364927
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1227602
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	419119
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	486615
CY2023Q4	gia	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	2895226
CY2022Q4	gia	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	1530299
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2895226
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1530299
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2895226
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2024Q1	gia	Common Stock Shares Issued Such That These Shares Represent Ownership By Investee In The Current Company CommonStockSharesIssuedSuchThatTheseSharesRepresentOwnershipByInvesteeInTheCurrentCompany	740000
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2024Q1	gia	Common Stock Shares Issued Such That These Shares Represent Ownership By Investee In The Current Company CommonStockSharesIssuedSuchThatTheseSharesRepresentOwnershipByInvesteeInTheCurrentCompany	740000
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001193125-24-075608-index-headers.html	Edgar Link	pending
0001193125-24-075608-index.html	Edgar Link	pending
0001193125-24-075608.txt	Edgar Link	pending
0001193125-24-075608-xbrl.zip	Edgar Link	pending
d767219d10k.htm	Edgar Link	pending
d767219dex14.htm	Edgar Link	pending
d767219dex211.htm	Edgar Link	pending
d767219dex311.htm	Edgar Link	pending
d767219dex312.htm	Edgar Link	pending
d767219d10k_htm.xml	Edgar Link	completed
d767219dex321.htm	Edgar Link	pending
d767219dex322.htm	Edgar Link	pending
d767219dex971.htm	Edgar Link	pending
d767219dex991.htm	Edgar Link	pending
d767219dex992.htm	Edgar Link	pending
d767219dex993.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gia-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
gia-20231231_cal.xml	Edgar Link	unprocessable
gia-20231231_def.xml	Edgar Link	unprocessable
gia-20231231_lab.xml	Edgar Link	unprocessable
gia-20231231_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QTI
QT IMAGING HOLDINGS, INC. Stock $qti

2024 Q1 Form 10-K Financial Statement

#000119312524075608 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QTI QT IMAGING HOLDINGS, INC. Stock $qti

2024 Q1 Form 10-K Financial Statement

#000119312524075608 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QTI
QT IMAGING HOLDINGS, INC. Stock $qti